| Study Name | Indication | Description | Location | Stipend | Apply |
|---|---|---|---|---|---|
| AFFINITY (PSA2003) | Psoriatic Arthritis | A Phase 2a, Multicenter, Randomized, Double-blind Study Evaluating the Efficacy and Safety of Subcutaneously Administered investigational medication Combination Therapy in Participants With Active Psoriatic Arthritis | Vandalia, Ohio | $936 | Apply |
| LG Gout Study | Refractory Gout | A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and controlled Phase 3 Study to Assess the Efficacy and Safety of an investigational medication in Gout Patients with hyperuricemia | Vandalia, Ohio | $2165 | Apply |
| NEPTUNUS-01 | Sjogren's Syndrome | A randomized, double-blind, placebo-controlled, 2-arm multicenter phase 3 study to assess the efficacy and safety of an investigational medication in patients with active Sjögren’s syndrome (NEPTUNUS-1) | Vandalia, Ohio | $1638 | Apply |
| MLS-101-202 | Hypertension | A Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of an investigational medication in Subjects with Uncontrolled Hypertension on a Standardized Medication Regimen | Springboro, Ohio | $500 | Apply |
| APEX (PSA3004) | Psoriatic Arthritis | A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants with Active Psoriatic Arthritis. | Springboro, Ohio | $1040 | Apply |
| TOPAZ-2 | Systemic Lupus Erythematosus | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of a new investigational product in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care | Springboro, Ohio | $7224 | Apply |
| Prostate Cancer Study | Prostate Cancer - General | A Multi-Center, Prospective, Observational Study of Patients Being Treated with ORGOVYX | Dayton, OH | $120 | Apply |